· BEYOND CELIAC · GLUTEN-FREE · GLUTEN-FREE CERTIFICATION PROGRAM · WWW.GF-CERT.ORG

LIVE

Serial Number

87542726

Owner

National Foundation for Celiac Awareness

Attorney

Ann K. Ford

First Use Date

Jul 25, 2017

Filing Date

Jul 25, 2017

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

· BEYOND CELIAC · GLUTEN-FREE · GLUTEN-FREE CERTIFICATION PROGRAM · WWW.GF-CERT.ORG Trademark

Serial Number: 87542726 • Registration: 6169697

· BEYOND CELIAC · GLUTEN-FREE · GLUTEN-FREE CERTIFICATION PROGRAM · WWW.GF-CERT.ORG is a trademark filed by National Foundation for Celiac Awareness on July 25, 2017. The trademark is classified under unclassified. The application is currently registered and active.

Owner Contact Info

National Foundation for Celiac Awareness (32 trademarks)

P.O. Box 544
Ambler, PA 19002

Entity Type: 99

Legal Representation

Attorney of Record

Ann K. Ford

5,439 trademarks filed View all →

Correspondence Address

Ann K. Ford DLA Piper LLP (US)

500 Eighth Street, NW

Washington, DC 20004

UNITED STATES

Trademark Details

Filing Date

July 25, 2017

Registration Date

October 6, 2020

First Use Anywhere

July 25, 2017

First Use in Commerce

July 25, 2017

Published for Opposition

December 19, 2017

Goods & Services

Food products; dietary supplements

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Oct 6, 2025 REM1

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Sep 14, 2022 TCCA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Sep 14, 2022 ARAA

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Sep 14, 2022 REAP

REGISTERED-PRINCIPAL REGISTER

Oct 6, 2020 R.PR

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Sep 2, 2020 SUNA

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Sep 1, 2020 CNPR

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 15, 2020 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 15, 2020 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 10, 2020 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Apr 20, 2020 GNRN

NON-FINAL ACTION E-MAILED

Apr 20, 2020 GNRT

SU - NON-FINAL ACTION - WRITTEN

Apr 20, 2020 CNRT

STATEMENT OF USE PROCESSING COMPLETE

Mar 9, 2020 SUPC

USE AMENDMENT FILED

Feb 11, 2020 IUAF

TEAS STATEMENT OF USE RECEIVED

Feb 11, 2020 EISU

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Nov 14, 2019 EXRA

SOU EXTENSION 3 GRANTED

Nov 13, 2019 EX3G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 12, 2019 AITU

NOTICE OF REVIVAL - E-MAILED

Oct 22, 2019 NREV

SOU EXTENSION RECEIVED WITH TEAS PETITION

Oct 22, 2019 TPEX

PETITION TO REVIVE-GRANTED

Oct 22, 2019 PETG

TEAS PETITION TO REVIVE RECEIVED

Oct 22, 2019 PROA

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Sep 16, 2019 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Sep 16, 2019 ABN6

SOU EXTENSION 3 FILED

Aug 13, 2019 EXT3

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 15, 2019 EXRA

SOU EXTENSION 2 GRANTED

Feb 13, 2019 EX2G

SOU EXTENSION 2 FILED

Feb 13, 2019 EXT2

SOU TEAS EXTENSION RECEIVED

Feb 13, 2019 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 15, 2018 EXRA

SOU EXTENSION 1 GRANTED

Aug 13, 2018 EX1G

SOU EXTENSION 1 FILED

Aug 13, 2018 EXT1

SOU TEAS EXTENSION RECEIVED

Aug 13, 2018 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Feb 13, 2018 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 19, 2017 NPUB

PUBLISHED FOR OPPOSITION

Dec 19, 2017 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 29, 2017 NONP

ASSIGNED TO LIE

Nov 12, 2017 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 1, 2017 CNSA

EXAMINER'S AMENDMENT ENTERED

Oct 30, 2017 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Oct 30, 2017 GNEN

EXAMINERS AMENDMENT E-MAILED

Oct 30, 2017 GNEA

EXAMINERS AMENDMENT -WRITTEN

Oct 30, 2017 CNEA

ASSIGNED TO EXAMINER

Oct 24, 2017 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Aug 1, 2017 MDSM

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jul 31, 2017 NWOS

NEW APPLICATION ENTERED

Jul 28, 2017 NWAP

Related Trademarks

More from this Owner

BEYOND CELIAC GLUTEN-FREE BEYONDCELIAC.ORG

BEYOND CELIAC TOGETHER FOR A CURE

BEYOND CELIAC CAPITAL MANAGEMENT